XML 20 R8.htm IDEA: XBRL DOCUMENT v3.7.0.1
Divestitures
3 Months Ended
Jun. 30, 2017
Discontinued Operations and Disposal Groups [Abstract]  
Divestitures
Divestitures

Divestitures
Late in the first quarter of fiscal 2017, the Company was approached and discussed the potential to sell certain businesses. Prior to these discussions, the Company did not contemplate any divestitures, and the Company did not commit to any course of action to divest any of the businesses until entering into an agreement on June 29, 2016 to sell Pediacare, New Skin and Fiber Choice, which were reported under the North American OTC Healthcare segment in the Cough & Cold, Dermatologicals and Gastrointestinal product groups, respectively. This transaction met the criteria as held for sale, and the related assets were measured at the lower of the carrying value or fair value less any costs to sell based on the agreed-upon sales price. As a result, in the first quarter of fiscal 2017, we recorded the held for sale assets at their estimated fair value and recorded a pre-tax loss on sale of $55.5 million.